Clinical Trial Update: Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual Function [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of a brimonidine tartrate posterior segment drug delivery system to improve visual function in rhegmatogen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhegmatogenous Retinal Detachment

Drugs mentioned

• Brimonidine tartrate posterior segment drug delivery system (brimonidine tartrate)

Snippet

Sponsor: Allergan | Conditions: Rhegmatogenous Macula-off Retinal Detachment | Phase 2 | Status: COMPLETED | Results posted: 2013-04-24